RY / FA
Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
17%
Leverage & Liquidity Bad
0%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamentals

Valuation

Metric Q1 Q2 Δ in %
EV/EBITDA -4.94 613.60 645.46
Graham Fair Price 6.82 73.54 68.85
PEG 27.82 1.19 -0.93
Price/Book -2.10 1.55 1.58
Price/Cash Flow 19.52 42.54 35.59
Prices/Earnings -7.33 11.93 12.88
Price/Sales 0.67 5.71 5.68
Price/FCF 19.52 42.54 35.59
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q1 Q2 Δ in %
Gross Profit Margin 0.00 1.00 1.00
Operating Margin 57.61 < 0.005 < 0.005
ROA 7.20 < 0.005 < 0.005
ROE 0.03 0.03 5.64
ROIC < 0.005 < 0.005 65.00
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q1 Q2 Δ in %
Debt QOQ -0.09 -0.11 21.12
Dividends QOQ 0.01 0.01 25.13
EBIT QOQ -1.00 0.60 -39.85
EPS QOQ -0.14 0.10 -27.50
FCF QOQ 1.44 -0.14 -89.90
Revenue QOQ 1.45 0.02 -98.96
Naive Interpretation member
03 - Financial Growth · Weak
Fundamentals

Leverage & Liquidity

Metric Q1 Q2 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 0.00 0.00 0.00
Days Sales Outstanding (DSO) 0.00 0.00 0.00
Inventory Turnover 0.00 0.00 0.00
Debt/Capitalization 0.77 0.75 -3.16
Quick Ratio 0.40 0.31 -22.51
Naive Interpretation member
04 - Leverage & Liquidity · Bad
Fundamentals

Per Share Metrics

Metric Q1 Q2 Δ in %
Book Value 82.76 86.01 3.93
Cash 265.97 232.05 -12.75
Capex -0.34 -0.29 15.32
Free Cash Flow 3.68 3.14 -14.88
Revenue 23.10 23.35 1.06
Naive Interpretation member
05 - Per Share Metrics · Weak
Fundamentals

Financial Health

Metric Q1 Q2 Δ in %
Current Ratio 0.74 0.65 -12.10
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 375.07 354.37 -5.52
Naive Interpretation Member
06 - Financial Health · Bad